4.7 Article

Modulation of peroxisome proliferator-activated receptor γ stability and transcriptional activity in adipocytes by resveratrol

期刊

METABOLISM-CLINICAL AND EXPERIMENTAL
卷 57, 期 7, 页码 S32-S38

出版社

W B SAUNDERS CO-ELSEVIER INC
DOI: 10.1016/j.metabol.2008.04.006

关键词

-

资金

  1. NCCIH NIH HHS [P50 AT002776-01, P50 AT002776, P50AT002776-01] Funding Source: Medline
  2. NIA NIH HHS [R03 AG025751-01A1, R03 AG025751] Funding Source: Medline
  3. NIDDK NIH HHS [R56 DK089020, P30 DK072476] Funding Source: Medline

向作者/读者索取更多资源

The peroxisome proliferator-activated receptor (PPAR) gamma is essential for the formation and function of adipocytes. It is also involved in regulating insulin sensitivity and is the functional target of the thiazolidinedione class of insulin-sensitizing drugs. Whereas thiazolidinediones activate PPAR gamma and decrease PPAR gamma protein levels, genetic models indicate that decreased expression of PPAR gamma is also associated with increased insulin sensitivity. In this study, we show that resveratrol modulates PPAR gamma protein levels in 3T3-L1 adipocytes via inhibition of PPAR gamma gene expression coupled with increased ubiquitin-proteasome-dependent degradation of PPAR gamma proteins. Resveratrol-mediated decreases in PPAR gamma expression are associated with repression of PPAR gamma transcriptional activity when assayed using a panel of PPAR gamma target genes in adipocytes. Finally, we demonstrate that resveratrol inhibits insulin-dependent changes in glucose uptake and glycogen levels and decreases insulin receptor substrate 1 and glucose transporter 4 protein levels, indicating that resveratrol represses insulin sensitivity in adipocytes. These results indicate that the resveratrol-mediated effects in adipocytes involve regulation of PPAR gamma expression and transcriptional activity along with decreased responsiveness to insulin. (C) 2008 Elsevier Inc. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据